Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2022 Publisher: Lundbeck Limited, Iveco House, Station Road, Watford, Hertfordshire, WD17 1ET, United Kingdom
Clopixol 200 mg/ml solution for injection.
Clopixol Conc. 500 mg/ml solution for injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. Clear, yellowish oil, practically free from particles. |
Clopixol Injection: Zuclopenthixol decanoate 200 mg/ml.
Clopixol Conc. Injection: Zuclopenthixol decanoate 500 mg/ml.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Zuclopenthixol |
Zuclopenthixol is a potent neuroleptic of the thioxanthene series with a piperazine side-chain. The antipsychotic effect of neuroleptics is related to their dopamine receptor blocking effect. |
| List of Excipients |
|---|
|
Thin vegetable oil |
Ampoules containing 1 ml of 200 mg/ml zuclopenthixol decanoate in thin vegetable oil.
Pack size: 10 ampoules per box. 10 ml clear glass vials with a rubber stopper secured with an aluminium collar having a fliptop cap. Pack size: 1 vial per box.
Ampoules containing 1 ml of 500 mg/ml zuclopenthixol decanoate in thin vegetable oil.
Pack size: 5 ampoules per box.
Lundbeck Limited, Iveco House, Station Road, Watford, Hertfordshire, WD17 1ET, United Kingdom
Clopixol Injection: PL 00458/0017
Clopixol Conc. Injection: PL 00458/0060
Date of First Authorisation in the UK:
Clopixol Injection: 15 May 1978
Clopixol Conc. Injection: 21 November 1988
Renewal of the Authorisation:
Clopixol Injection: 3 July 2008
Clopixol Conc. Injection: 3 July 2008
| Drug | Countries | |
|---|---|---|
| CLOPIXOL | Australia, Brazil, Canada, Cyprus, Germany, Spain, France, Hong Kong, Ireland, Israel, Malta, Mexico, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
